Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: A Cancer and Leukemia Group B study

British Journal of Haematology

Volumn 101, Issue 3, 1998, Pages 513-520

  Heinonen, Kristiina ^a,j   Mrózek, Krzysztof ^b,n   Lawrence, David ^a   Arthur, Diane C ^c,k   Pettenati, Mark J ^d   Stamberg, Judith ^e   Qumsiyeh, Mazin B ^f   Verma, Ram S ^g,l   Maccallum, Jane ^h   Schiffer, Charles A ^i,m   Bloomfield, Clara D ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WAKE FOREST BAPTIST HEALTH   (United States)

^e UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g WEILL CORNELL MEDICAL CENTER   (United States)

^h SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^j KUOPIO UNIVERSITY HOSPITAL   (Finland)

^k NATIONAL CANCER INSTITUTE   (United States)

^l Inst of Molec Biology and Genetics   (United States)

^m WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

Acute myeloid leukaemia; Chromosome pair 11; Prognosis; Trisomy

Indexed keywords

CYTARABINE; DAUNORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHROMOSOME 11; CLINICAL ARTICLE; DISEASE ACTIVITY; HUMAN; KARYOTYPE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SURVIVAL RATE; THROMBOCYTE COUNT; TRISOMY;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 11; CYTARABINE; DAUNORUBICIN; FEMALE; HUMANS; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; TREATMENT OUTCOME; TRISOMY;

EID: 7144222767     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00714.x     Document Type: Article

References (62)

1. Avauzi, G.C., Giovinazzo, B., Rosso, A., Depaoli, L., Bertini, M., Resegotti, L. & Pegoraro, L. (1989) Trisomy 11 in myelodysplastic syndrome-derived acute mycloblaslic leukaemias. European Journal of Haematology, 43, 173-177.
2. Bartram, C.R., Ludwig, W.-D., Hiddemann, W., Lyons, J., Buschle, M., Ritter, J., Harbott, J., Fröhlich, A. & Janssen, J.W.G. (1989) Acute myeloid leukemia: analysis of Ras gene mutations and clonality defined by polymorphic X-linked loci. Leukemia, 3, 247-256.
3. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 620-629.
4. Bergamaschi, G., Stella, C.C., Cattoretti, G., Invernizzi, R., Maserati, E., Nalli, G., Pedrazzoli, P., Peverali, F.A., Valle, G.D., Ascari, E. & Cazzola, M. (1991) Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. British Journal of Haematology, 78, 167-172.
5. Berger, R., Flandrin, G., Bernheim, A., Le Coniat, M., Vecchione, D., Pacot, A., Derré, J., Daniel, M-T., Valensi, F., Sigaux, F. & Ochoa-Noguera, M.E. (1987) Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genetics and Cytogenetics, 29, 9-21.
6. Bernard, O.A., Romana, S.P., Schichman, S.A., Mauchauffé, M., Jonveaux, P. & Berger, R. (1995) Partial duplication of HRX in acute leukemia with trisomy 11. Leukemia, 9, 1487-1490.
7. Bilhou-Nabera, C., Lesesve, J.-F., Marit, G., Lafage, M., Dastugue, N., Goullin, B., Arnoulet, C., Stoppa, A.-M., Huguet, E. Attal, M., Lacombe, F., Braustet, A., Reiffers, J. & Bernard, P. (1994) Trisomy 11 in acute myeloid leukemia: ten cases. Leukemia, 8, 2240-2241.
8. Bloomfield, C.D. & de la Chapelle, A. (1987) Chromosome abnormalities in acute nonlymphocytic leukemia: clinical and biologic significance. Seminars in Oncology, 14, 372-383.
9. Caligiuri, M.A., Strout, M.P., Schichman, S.A., Mrózek, K., Arthur, D.C., Herzig, G.P., Baer, M.R., Schiffer, C.A., Heinonen, K., Knuutila, S., Nousiainen, T., Ruutu, T., Block, A.W., Schulman, P., Pedersen-Bjergaard, J., Croce, C.M. & Bloomfield, C.D. (1996) Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Research, 56, 1418-1425.
10. Cuneo, A., Balboni, M., Carli, M.G., Bigoni, R., Roberti, G., Pazzi, I., Previati, R. & Castoldi, G. (1994) Involvement of erythrocytic and granulomonocytic lineages by trisomy 11 in two cases of acute myelomonocytic leukemia with trilineage myelodysplasia: an interphase cytogenetic study. Cancer Genetics and Cytogenetics, 77, 33-38.
11. Cuneo, A., Michaux, J.-L., Ferrant, A., Van Hove, L., Bosly, A., Stul, M., Dal Cin, P., Vandenberghe, E., Cassiman, J.-J., Negrini, M., Piva, N., Castoldi, G. & Van den Berghe, H. (1992) Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood, 79, 720-727.
12. Dang, C.V., Stein, P.H., Gress, D.R., Dallabetta, G.A. & Bender, W.L. (1985) A case of agnogenic myeloid metaplasia evolving into acute myelogenous leukemia associated with the development of trisomy 11 in bone marrow cells. American Journal of Hematology, 19, 285-288.
13. Döhner, H., Arthur, D.C., Ball, E.D., Sobol, R.E., Davey, F.R., Lawrence, D., Gordon, L., Patil, S.R., Surana, R.B., Testa, J.R., Verma, R.S., Schiffer, C.A., Wurster-Hill, D.H. & Bloomfield, C.D. (1990) Trisomy 13: a new recurring chromosome abnormality in acute leukemia. Blood, 76, 1614-1621.
14. Fagioli, F., Cuneo, A., Carli, M.G., Bardi, A., Piva, N., Previati, R., Rigolin, G.M., Ferrari, L., Spanedda, R. & Castoldi, G. (1993) Chromosome aberrations in CD34-positive acute myeloid leukemia: correlation with clinicopathologic features. Cancer Genetics and Cytogcnetics, 71, 119-124.
15. Fitzgerald, P.H., Morris, C.M., Fraser, G.J., Giles, L.M., Hamer, J.W., Heaton, D.C. & Beard, M.E.J. (1983) Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemia. Cancer Genetics and Cytogenetics, 8, 51-66.
16. Fourth International Workshop on Chromosomes in leukemia. 1982 (1984) Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. Cancer Genetics and Cytogenetics, 11, 332-350.
17. Furuya, T., Morgan, R. & Sandberg, A.A. (1992) Cytogenetic biclonality in malignant hematologic disorders. Cancer Genetics and Cytogenetics, 62, 25-28.
18. Gangji, D., Noseda, A., Wybran, J. & Verhest, A. (1985) Trisomy 11 in preleukemia. Cancer Genetics and Cytogenetics, 14, 119-125.
19. Ghaddar, H.M., Pierce, S., Reed, P. & Estey, E.H. (1995) Prognostic value of residual normal metaphases in acute myelogenous leukemia patients presenting with abnormal karyotype. Leukemia, 9, 779-782.
20. Goasguen, J.E., Matsuo, T., Cox, C. & Bennett, J.M. (1992) Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival. Leukemia, 6, 520-525.
21. Groupe Français de Cytogénétique Hématologique (GFCH) (1984) Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: a cooperative study. Cancer Genetics and Cytogenetics, 12, 95-104.
22. Gustavsson, A., Mitelman, K, Olofsson, T., Olsson, I. (1984) The relationship between growth in agar, karyotype and prognosis in acute leukaemia. Scandinavian Journal of Haematology, 32, 351-363.
23. Haferlach, T., Bennett, J.M., Löffler, H., Gassmann, W., Andersen, J.W., Tuzuner, N., Cassileth, P.A., Fonatsch, C., Schoch, C., Schlegelberger, B., Becher, R., Thiel, E., Ludwig, W.-D., Sauerland, M.C., Heinecke, A. & Büchner, T., for the AML Cooperative Group and ECOG (1996) Acute myeloid leukemia with translocation (8:21): cytomorphology, dysplasia and prognostic factors in 41 cases. Leukemia and Lyinphoma, 23, 227-234.
24. Hagemeijer, A., Hählen, K. & Abels, J. (1981) Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics, 3, 109-124.
25. Hamblin, T.J. & Oscier, D.G. (1987) The myelodysplastic syndrome: a practical guide. Hematological Oncology, 5, 19-34.
26. Heim, S. & Mitelman, F. (1995) Acute myeloid leukemia. Cancer Cytogenetics. 2nd edn. pp. 69-140. Wiley-Liss, New York.
27. Hurwitz, C.A., Raimondi, S.C., Head, D., Krance, R., Mirro, J., Jr, Kalwinsky, U.K., Avers, G.D. & Behm, F.G. (1992) Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood, 80, 3182-3188.
28. Ingram, L., Raimondi, S.C., Mirro, J., Jr, Rivera, G.K., Ragsdale, S.T. & Behm, F. (1989) Characteristics of trisomy 11 in childhood acute leukemia with review of the literature. Leukemia, 3, 695-698.
29. ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). Karger, Basel.
30. Johansson, B., Mertens, F., Heim, S., Kristoffersson, U. & Mitelman, F. (1991) Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL). European Journal of Haematology, 47, 17-27.
31. Kadam, P.R., Merchant, A.A., Advani, S.H. & Nair, C. (1991) Specific chromosomal changes in patients with acute nonlymphocytic leukemia from India. Hematological Oncology, 9, 17-32.
32. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
33. Keinänen, M., Bloomfield, C.D., Machnicki, J., Griffin, J.D. & de la Chapelle, A. (1989) Human bone marrow cytogenetics: growth factors stimulate metaphases for specific lineages. Leukemia, 3, 405-412.
34. Kouides, P.A. & Bennett, J.M. (1996) Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Seminars in Hematology, 33, 95-110.
35. Kuriyama, K., Tomonaga, M., Matsuo, T., Kobayashi, T., Miwa, H., Shirakawa, S., Tanimoto, M., Adachi, K., Emi, N., Hiraoka, A., Tominaga, N., Imai, K., Asou, N., Tsubaki, K., Takahashi, I., Minami, S., Yoshida, M., Murakami, H., Minato, K., Oshima, T., Furusawa, S., Ohno, R., and Japan Adult Leukaemia Study Group (JALSG) (1994) Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. British Journal of Haematology, 86, 767-773.
36. Li, Y.S., Khalid, G. & Hayhoe, F.G.J. (1983) Correlation between chromosomal pattern, cytological subtypes, response to therapy. and survival in acute myeloid leukaemia. Scandinavian Journal of Haematology, 30, 265-277.
37. Marosi, C., Köller, U., Koller-Weber, E., Schwarzinger, I., Schneider, B., Jäger, U., Vahls, P., Nowotny, H., Pirc-Danoewinata, H., Steger, G., Kreiner, G., Wagner, B., Lechner, K., Lutz, D., Bettelheim, P. & Haas, O.A. (1992) Prognostic impact of karyotype and immunologie phenotype in 125 adult patients with de novo AML. Cancer Genetics and Cytogenetics, 61, 14-25.
38. Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. & Frei, E., III. for the Cancer and Leukemia Group B. (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. New England Journal of Medicine, 331, 896-903.
39. Mayer, R.J., Schiffer, C.A., Peterson, B.A., Silver, R.T., Cornwell, G.G., Mclntyre, O.R., Rai, K.R., Budman, D.R., Ellison, R.R., Maguire, M., Davis, R.B. & Frei, E., III (1985) Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I study. Seminars in Oncology, 12, (Suppl. 3). 84-90.
40. Mitelman, F. (1994) Catalog of Chromosome Aberrations in Cancer, 5th edn. Wiley-Liss, New York.
41. Moore, J.O., Dodge, R.K., Amrein, P.C., Kolitz, J., Lee, E.J., Powell, B., Godfrey, S., Robert, F. & Schiffer, C.A. (1997a) Granulocyte colonystimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. Blood, 89, 780-788.
42. Moore, J.O., Powell, B., Velez-Garcia, E., Kolitz, J., George, S., Dodge, R., Rizzieri, D.A. & Schiffer, C. (1997b) A comparison of sequential non-cross-resistant therapy or Ara-C consolidation following complete remission in adult patients <60 years with acute myeloid leukemia: CALGB 9222. Proceedings of the Annual Meeting of American Society of Clinical Oncology, 16, 14a.
43. Morgan, R., Greene, M.H. & Sandberg, A.A. (1988) Trisomy 11 in myelodysplasia. Cancer Genetics and Cytogenetics, 30, 159-162.
44. Mrózek, K., Heinonen, K., de la Chapelle, A. & Bloomfield, C.D. (1997) Clinical significance of cytogenetics in acute myeloid leukemia. Seminars in Oncology, 24, 17-31.
45. Nakamura, H., Jubashi, T., Jinnai, I., Sasagawa, I., Itoyama, T., Tokunaga, S., Moriuchi, Y., Sadamori, N. & Ichimaru, M. (1989) Trisomy of chromosome 11 in a case of common ALL antigen-positive acute myeloblastic leukemia. [In Japanese]. Rinsho Ketsueki: Japanese Journal of Clinical Hematology, 30, 2220-2224.
46. Najfeld, V., Chen, A., Scalise, A., Ambinder, E.P., Fernandez, G. & Waxman, S. (1994) Myelodysplastic syndrome transforming to acute promyelocytic-like leukemia with trisomy and rearrangement of chromosome 11. Genes, Chromosomes and Cancer, 10, 15-25.
47. Ohyashiki, K., Nagasu, M., Hojo, H., Iwabuchi, A., Ohyashiki, J.H. & Toyama, K. (1989) Myelodysplastic syndrome with trisomy 11 associated with polycythemia vera. American Journal of Hematology, 31, 122-125.
48. Ohyashiki, K., Ohyashiki, J.H., Iwabuchi, A., Toyama, K., Fukui, M., Yoshitake, H. & Okajima, S. (1988) Trisomy 11 in nonlymphocytic neoplasia. British Journal of Haematology, 69, 420.
49. Rubin, C.M., Arthur, D.C., Woods, W.G., Lange, B.J., Nowell, P.C., Rowley, J.D., Nachman, J., Bostrom, B., Baum, E.S., Suarez, C.R., Shah, N.R., Morgan, E., Maurer, H.S., McKenzie, S.E., Larson, R.A. & Le Beau, M.M. (1991) Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood, 78, 2982-2988.
50. Satake, N., Sakashita, A., Kobayashi, H., Maseki, N., Sakurai, M. & Kaneko, Y. (1997) Minimal residual disease in acute monocytic leukemia patient with trisomy 11 and partial tandem duplication of MLL. Cancer Genetics and Cytogenetics, 96, 26-29.
51. Slovak, M.L., Traweek, S.T., Willman, C.L., Head, D.R., Kopecky, K.J., Magenis, R.E., Appelbaum, F.R. & Forman, S.J. (1995) Trisomy 11: an association with stem/progenitor cell immunophenotype. British Journal of Haematology, 90, 266-273.
52. Stone, R.M., Berg, D.T., George, S.L., Dodge, R.K., Paciucci, P.A., Schulman, P., Lee, K.J., Moore, J.O., Powell, B.L. & Schiffer, C.A., for the Cancer and Leukemia Group B (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. New England Journal of Medicine, 332, 1671-1677.
53. Suciu, S., Kuse, R., Weh, H.J. & Hossfeld, D.K. (1990) Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genetics and Cytogenetics, 44, 15-26.
54. Suciu, S., Zeller, W., Weh, H.J. & Hossfeld, U.K. (1995) Immunophenotype of mitotic cells with clonal chromosome abnormalities demonstrating multilineage involvement in acute myeloid leukemia. Cancer Genetics and Cytogenetics, 70, 1-5.
55. Takasaki, N., Kaneko, Y., Maseki, N. & Sakurai, M. (1988) Trisomy 11 in chronic myelomonocytic leukemia: report of two cases and review of the literature. Cancer Genetics and Cytogenetics, 30, 109-117.
56. Testa, J.R., Misawa, S., Oguma, N., Van Sloten, K. & Wiernik, P.H. (1985) Chromosomal alterations in acute leukemia patients studied with improved culture methods. Cancer Research, 45, 430-434.
57. Tien, H.-F., Wang, C.-H., Su, J.-J., Liu, F.-S., Wu, H.-S., Chen, Y.-C., Lin, K.-H., Lee, S.-C. & Shen, M.-C. (1990) A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7: morphologic, cytochemical, immunocytochemical and T cell receptor gene analysis on 13 patients. Leukemia Research, 14, 515-523.
58. Trakhtenbrot, L., Rosner, E., Gipsh, N., Berman, S., Sofer, O., Brok-Simoni, F., Rechavi, G. & Ben-Bassat, I. (1995) Hexasomy of chromosome 8 and trisomy of chromosome 11 characterize two karyotypically independent clones in a case of acute nonlymphocytic leukemia; conventional cytogenetic and FISH investigation. Cancer Genetics and Cytogenetics, 85, 1-4.
59. United Kingdom Cancer Cytogenetics Group (UKCCG) (1992) Primary, single, autosomal trisomies associated with haematological disorders, Leukemia Research, 16, 841-851.
60. Weh, H.J., Hoffmann, R., Suciu, S., Kuse, R. & Hossfeld, D.K. (1988) Is trisomy 11 another nonrandom chromosomal anomaly in acute nonlymphocytic leukemia and myelodysplastic syndromes? Cancer Genetics and Cytogenetics, 35, 205-211.
61. Yamamoto, K., Hamaguchi, H., Nagata, K., Kobayashi, M. & Taniwaki, M. (1997) Tandem duplication of the MLL gene in myelodysplastic syndrome-derived overt leukemia with trisomy 11. American Journal of Hematology, 55, 41-45.
62. Yunis, J.J., Bloomfield, C.D. & Ensrud, K. (1981) All patients with acute nonlymphocytic leukemia may have a chromosomal defect. New England Journal of Medicine, 305, 135-139.